No effect of spironolactone on bulimia nervosa symptoms

J Clin Psychopharmacol. 2008 Apr;28(2):258-60. doi: 10.1097/JCP.0b013e3181678a17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Bulimia Nervosa / drug therapy*
  • Bulimia Nervosa / pathology
  • Diagnostic and Statistical Manual of Mental Disorders
  • Double-Blind Method
  • Female
  • Humans
  • Middle Aged
  • Mineralocorticoid Receptor Antagonists / administration & dosage
  • Mineralocorticoid Receptor Antagonists / therapeutic use
  • Mineralocorticoids / administration & dosage
  • Mineralocorticoids / therapeutic use
  • Randomized Controlled Trials as Topic
  • Spironolactone / administration & dosage
  • Spironolactone / therapeutic use*
  • Treatment Failure

Substances

  • Mineralocorticoid Receptor Antagonists
  • Mineralocorticoids
  • Spironolactone